Conference on Photodynamic Therapy

描述（由申请人提供）： 该提案要求支持将与2002年在加拿大魁北克市举行的美国光生物学学会会议一起举行的光动力疗法最新发展专题讨论会。 已经确定了一个组织委员会，会议将能够利用缔约方大会的设施，选择旅馆、宣布和处理所提供的文件和海报提案的机制。 由于2002年没有其他主要的PDT会议，这将是该领域工作者从主要实验室获得最新研究成果和交流更多信息的机会。 会议将集中讨论：细胞死亡的机制，细胞对PDT的反应和分子靶点的光敏失活。 这将包括细胞死亡的三种模式，但也包括一些关于诱导细胞因子和使用PDT接近一些分子靶点的较新工作（例如，生长因子受体和PKC）。 ASP会议的典型注册人数为350-400人，但增加一个实质性的PDT专题讨论会预计将吸引更多的与会者。 最近的PDT会议由国际光动力学协会主办，有600多名与会者。

DESCRIPTION (provided by applicant): This proposal requests support for a Symposium on recent developments in Photodynamic Therapy, to be held in conjunction with the 2002 meeting of the American Society for Photobiology in Quebec City, Canada. An organizing committee has been identified, and the meeting will be able to take advantage of the ASP facilities with regard to hotel selection, announcements and mechanisms for dealing with proffered papers and poster proposals. Since there is no other major PDT conference in 2002, this will be an opportunity for workers in the field to receive updates on research from major laboratories and exchange additional information. The meeting will concentrate on: mechanisms of cell death, cellular responses to PDT and photosensitized inactivation of molecular targets. This will encompass the three modes of cell death but also include some of the newer work on induction of cytokines and the use of PDT to approach some of the molecular targets (e.g., growth factor receptors and PKC). The typical registration for ASP meetings is 350-400, but the addition of a substantial PDT symposium is expected to attract additional participants. The most recent PDT meeting, sponsored by the International Photodynamic Assn, has more than 600 participants.